Baxter's (BAX) Latest FDA Approval to Boost Infusion Therapy
Baxter's (BAX) Latest FDA Approval to Boost Infusion Therapy
Baxter’s Novum IQ Launch: A Hold Rating Amid Competitive Challenges and Market Opportunities
Analysts Offer Insights on Healthcare Companies: Humana (HUM), Baxter International (BAX) and Biomea Fusion (BMEA)
Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy
Baxter to Host Annual Meeting of Stockholders in Virtual Format
Should You Hold Baxter International (BAX)?
Baxter to close Massachusetts site, lay off 59 people
Insider Sell: EVP, Chief HR Officer Jeanne Mason Sells 64,488 Shares of Baxter International ...
Dialysis firms gain as Ozempic kidney trial data disappoints
Baxter International Hold Rating: Assessing Kidney Care Asset Sale Versus Spin-Off
Recent
price
P/E
ratio
div
yld
2.87%
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.